---
title: "Emergent Biosolutions (EBS.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/EBS.US/norm.md"
symbol: "EBS.US"
name: "Emergent Biosolutions"
parent: "https://longbridge.com/zh-HK/quote/EBS.US.md"
datetime: "2026-05-20T07:48:15.961Z"
locales:
  - [en](https://longbridge.com/en/quote/EBS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EBS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EBS.US/norm.md)
---

# Emergent Biosolutions (EBS.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.0743 | -1.04 | 0.9100 | -0.2214 | 1.19 |
| ROE | 5.20% | -39.53% | 36.61% | -8.82% | 52.53% |
| 營業收入 | 156.10M | 148.70M | 231.10M | 140.90M | 222.20M |
| 凈利潤 | 6.80M | -54.60M | 51.20M | -12.00M | 68.00M |
| 營業利潤 | 10.60M | -22.60M | 87.30M | 500000.00 | 50.90M |
| 毛利率 | 47.21% | 36.79% | 57.16% | 43.08% | 53.83% |
| 凈利率 | 4.36% | -36.72% | 22.15% | -8.52% | 30.60% |
| 利潤含金量 | -31.36% | -29.09% | -3795.65% | 0.47% | -454.46% |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 1.32B | 1.32B | 1.46B | 1.42B | 1.43B |
| 權益乘數 | 2.52 | 2.52 | 2.51 | 2.64 | 2.58 |
| 每股凈資產 | 10.10 | 10.02 | 11.05 | 9.99 | 10.14 |
| 資產周轉率 | 0.4928 | 0.5486 | 0.5369 | 0.5812 | 0.5978 |
| 現金及短投 | 160.30M | 205.40M | 245.50M | 267.30M | 149.10M |
| 存貨與應收 | 327.60M | 343.40M | 356.30M | 338.60M | 314.00M |
| 長期投資 | 209.30M | 216.00M | 217.00M | 223.80M | 227.60M |
| 凈債務 | 424.30M | 378.30M | 425.50M | 408.80M | 523.60M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -33.80M | 77.70M | -2.30M | 106.40M | -11.20M |
| 投資現金流 | -2.40M | -3.90M | -3.40M | 17.20M | 59.50M |
| 融資現金流 | -11.40M | -113.90M | -15.90M | -6.40M | -400000.00 |
| 自由現金流 | 25.93M | 90.17M | -437500.00 | 166.31M | -23.09M |
| 現金流充裕率 | -1408.33% | 70.96% | -22.33% | 3668.97% | -311.11% |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | -2.40M | -3.90M | -3.40M | -2.90M | -3.60M |